Rare diseases
Investigational molecules
Locations
9 Rue Rameau, 75002 Paris, France
Bioprojet Pharma focuses on narcolepsy, narcolepsy with cataplexy, and related excessive daytime sleepiness, with clinical activity spanning both paediatric and adult populations.
The sponsor’s work in this area also includes treatment evaluation in patients with sleep-related symptoms and associated functional impairment.
Bioprojet Pharma runs clinical trials in conditions such as Narcolepsy, Obsessive-compulsive disorder, Premature ejaculation, Essential tremor, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A study testing the safety and effectiveness of BP1.
ItalyStudy on the Effectiveness of BP1.4979 for Adult Men with Premature Ejaculation
FranceRelative Bioavailability of Pitolisant Tablets in Healthy Male Subjects for Narcolepsy Treatment
BelgiumStudy on the Effectiveness of BP1.4979 for Adults with Essential Tremor
FranceStudy on the Safety and Effectiveness of Pitolisant for Children Aged 6-17 with Narcolepsy, with or without Cataplexy
FranceStudy on BP1.7881 for Adults with Eosinophilic Esophagitis
FranceStudy on BP1.4979 for Treating Binge Eating Disorder in Women with Moderate to Severe Symptoms
FranceStudy on the Effectiveness and Safety of BP1.7881 for Adults with Moderate-to-Severe Atopic Dermatitis
FranceStudy on the Effects of Pitolisant for Children and Adolescents with Autism Spectrum Disorder
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
